Pelthos Therapeutics Inc. Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-18: Form ARS; Period of report 2025-12-31; Description ARS; Document pths-20251231xfinalprintre.pdf.
- 2025-12-01: Form ARS; Period of report 2024-12-31; Description ARS; Document g085031_ars.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-18 | ARS | 2025-12-31 | ARS | pths-20251231xfinalprintre.pdf |
| 2025-12-01 | ARS | 2024-12-31 | ARS | g085031_ars.pdf |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |